AI assistant
Vericel Corp — Director's Dealing 2021
Feb 22, 2021
31799_dirs_2021-02-22_3e876304-ee18-43aa-a6a1-215c20b78b02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2021-02-19
Reporting Person: Flynn Sean C. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-19 | Stock Option (right to buy) | $51.40 | A | 3890 | Acquired | 2031-02-19 | Common Stock (3890) | Direct |
| 2021-02-19 | Restricted Stock Unit | $ | A | 7000 | Acquired | Common Stock (7000) | Direct | |
| 2021-02-19 | Stock Option (right to buy) | $51.40 | A | 56110 | Acquired | 2031-02-19 | Common Stock (56110) | Direct |
Footnotes
F1: These options shall begin vesting on February 19, 2021 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 19, 2022. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively.
F4: No expiration date for this type of award.